For a company already filing electronically, promotional submissions use a gateway that is already there. For a newly commercial company whose first gateway submission is a 2253, it is three lead times stacked on top of each other — usually discovered after a piece is approved.
Key takeaways
- Promotional submissions travel through the FDA Electronic Submissions Gateway like every other eCTD submission.
- An ESG account, a successful gateway test and OPDP’s structural review are three separate lead times.
- Choose WebTrader or AS2 for your promotional volume, not your current filing volume.
- Set the first dissemination date only after all three are done — there is no slack afterwards.
The eCTD requirement for promotional materials means they travel the same road as every other electronic submission: through the FDA Electronic Submissions Gateway (ESG). For a company already filing INDs and NDAs electronically, that is a non-event. For a newly commercial company whose first-ever gateway submission is a 2253, it is not.
Three lead times
The ESG account is a multi-step process with FDA that has to start well before your first electronic submission. A successful test submission is required of new gateway users before production use, validating connectivity, certificate configuration and acknowledgement routing.
The third is the one people do not know exists. OPDP’s structural review is separate from the gateway test, run by a different team, and addresses a different failure: the gateway test proves you can transmit; the OPDP review proves you have assembled a promotional submission correctly.
The gateway test proves you can transmit. OPDP’s review proves you assembled it correctly.
WebTrader or AS2
Promotional submissions are the use case that most often changes this decision. A company filing four sequences a year is comfortably a WebTrader shop. The same company running an active promotional programme — where each piece, revision and campaign wave generates a submission tied to a dissemination date — can see its volume rise by an order of magnitude, and fully manual transmission becomes the bottleneck.
Getting an account
The first step is to request a test account. For AS2, the registration URL and a temporary login come from the FDA ESG administrator after you email the ESG help desk to say you intend to register. Once the test account is issued and the centre-compliant test passes, you receive production credentials. FDA’s recurring advice is to start well before the first submission: certificates, account provisioning and a successful test are not same-week activities.
OPDP’s test submission process
OPDP’s review exists so submitters can validate eCTD structure before production. Review the presentations on the OPDP eCTD page; contact the OPDP eCTD mailbox with your questions, the submission types you will use (2253, advisory, accelerated approval) and your availability; attend a short planning meeting; submit the test files and report the result; and receive OPDP’s feedback. It is a review of your work by the people who will receive the real thing, at no cost.
The failure this prevents: a launch date fixed by commercial, a piece approved through MLR, and a regulatory operations team discovering days before dissemination that the gateway account does not exist yet. This article is general information, not regulatory advice — check the current FDA ESG and OPDP pages.
Promotional submissions, ready before launch
DnXT Publisher builds and validates promotional sequences — single and grouped — so the package is ready the day a piece is approved.
